FDA Briefing Document: Vaccines and Related Biological Products Advisory Committee Meeting
Access Resources
About
This document from October 22, 2020 focuses on the development and approval of COVID-19 vaccines. It describes the challenges posed by the pandemic and outlines efforts to create safe and effective vaccines quickly. It highlights different vaccine technologies being tested in clinical trials and also explains legal requirements for vaccine approval or emergency use authorization (EUA). The FDA emphasizes safety evaluations, including studies on special populations like children and pregnant women. Overall, it stresses transparency while ensuring that only safe vaccines are approved for public use.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.